Health care professionals can have a powerful impact on labeling requirements for drugs by formally petitioning the FDA for ...

The drugs have soared in popularity, with some men taking them for unapproved uses like anti-aging or increasing muscle mass.

The U.S. Food and Drug Administration has approved an updated label for Unloxcyt (cosibelimab-ipdl) for the treatment of ...

Promo materials should also refrain from positioning one approved biosimilar as better than another for the same reference ...

More recently, the FDA posted two two letters: one backdated for September 9, regarding GSK’s HIV medication Apretude and one ...

US drugmaker Pfizer has brought its Rimegepant (Orally Disintegrating Tablet -ODT) to India, to treat acute migraine, in adults with a previous insufficient response to triptan. “The new medication ...

Pfizer launches new migraine drug in India (Image Source: Freepik) Drug maker Pfizer on Monday introduced a new migraine treatment in India, offering hope to millions who struggle with severe and ...

https://www.thehindubusinessline.com/companies/pfizer-launches-new-medication-for-migraine-treatment/article70290052.ece Copy Drug maker Pfizer on Monday said it has ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min The FDA has restricted the type ...

More than 11,000 bottles of a widely prescribed blood pressure medication have been pulled from pharmacy shelves nationwide ...

Based on this analysis, all 3 gepants are not cost-effective compared with usual care for the treatment of acute migraine. Objective: Migraine is a debilitating chronic disorder requiring multifaceted ...